Clinical Study of the Efficacy of the Ophthalmic Emulsion PRO-145 for Inflammation and Pain After Phacoemulsification

NCT03693989 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

178

Enrollment

INDUSTRY

Sponsor class

Conditions

Cataract

Interventions

DRUG: Difluprednate 0.05%
DRUG: Prednefrin

Sponsor

Laboratorios Sophia S.A de C.V.